ArticleFrontiers in pharmacology2022

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study.

Stanislas Faguer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.